News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
223,480 Results
Type
Article (6493)
Company Profile (52)
Press Release (216927)
Multimedia
Podcasts (27)
Webinars (3)
Section
Business (73574)
Career Advice (642)
Deals (13609)
Drug Delivery (51)
Drug Development (9033)
Employer Resources (32)
FDA (3994)
Job Trends (5611)
News (104101)
Policy (9908)
Tag
2027 Pharm Country Standard (2)
Academia (824)
Accelerated approval (5)
Adcomms (7)
Allergies (39)
Alliances (21551)
ALS (18)
Alzheimer's disease (268)
Antibody-drug conjugate (ADC) (47)
Approvals (4043)
Artificial intelligence (170)
Autoimmune disease (20)
Automation (16)
Bankruptcy (112)
Best Places to Work (4721)
BIOSECURE Act (11)
Biosimilars (64)
Biotechnology (28)
Bladder cancer (29)
Brain cancer (8)
Breast cancer (119)
Cancer (945)
Cardiovascular disease (81)
Career advice (545)
Career pathing (9)
CAR-T (47)
CDC (34)
Celiac Disease (1)
Cell therapy (178)
Cervical cancer (10)
Clinical research (7761)
Collaboration (608)
Company closure (1)
Compensation (592)
Complete response letters (9)
COVID-19 (656)
CRISPR (18)
C-suite (244)
Cystic fibrosis (15)
Data (991)
Decentralized trials (1)
Denatured (7)
Depression (29)
Diabetes (77)
Diagnostics (3347)
Digital health (23)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (82)
Drug pricing (108)
Drug shortages (6)
Duchenne muscular dystrophy (36)
Earnings (26775)
Editorial (21)
Employer branding (3)
Employer resources (29)
Events (25508)
Executive appointments (351)
FDA (4829)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (353)
Gene editing (29)
Generative AI (9)
Gene therapy (127)
GLP-1 (170)
Government (2245)
Grass and pollen (5)
Guidances (204)
Healthcare (8565)
HIV (14)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (18)
Immuno-oncology (9)
Indications (25)
Infectious disease (729)
Inflammatory bowel disease (41)
Inflation Reduction Act (11)
Influenza (36)
Intellectual property (40)
Interviews (103)
IPO (5687)
IRA (34)
Job creations (980)
Job search strategy (457)
JPM (8)
Kidney cancer (2)
Labor market (41)
Layoffs (119)
Leadership (5)
Legal (2025)
Liver cancer (12)
Longevity (3)
Lung cancer (109)
Lymphoma (77)
Machine learning (8)
Management (8)
Manufacturing (403)
MASH (31)
Medical device (5177)
Medtech (5202)
Mergers & acquisitions (8370)
Metabolic disorders (183)
Multiple sclerosis (26)
NASH (3)
Neurodegenerative disease (34)
Neuropsychiatric disorders (12)
Neuroscience (469)
NextGen: Class of 2026 (3064)
Non-profit (2354)
Now hiring (10)
Obesity (63)
Opinion (56)
Ovarian cancer (14)
Pain (36)
Pancreatic cancer (29)
Parkinson's disease (38)
Partnered (15)
Patents (81)
Patient recruitment (63)
Peanut (14)
People (22036)
Pharmaceutical (14)
Pharmacy benefit managers (16)
Phase 1 (2070)
Phase 2 (3256)
Phase 3 (2838)
Pipeline (1538)
Policy (164)
Postmarket research (387)
Preclinical (869)
Press Release (66)
Prostate cancer (60)
Psychedelics (14)
Radiopharmaceuticals (79)
Rare diseases (135)
Real estate (3188)
Recruiting (16)
Regulatory (6789)
Reports (17)
Research institute (792)
Resumes & cover letters (98)
RNA editing (1)
RSV (12)
Schizophrenia (39)
Series A (35)
Series B (27)
Service/supplier (13)
Sickle cell disease (28)
Special edition (8)
Spinal muscular atrophy (18)
Sponsored (17)
Startups (954)
State (1)
Supply chain (52)
Tariffs (20)
The Weekly (20)
Vaccines (197)
Venture capital (12)
Weight loss (42)
Women's health (27)
Worklife (3)
Date
Last 7 days (172)
Last 30 days (603)
Last 365 days (7920)
2026 (756)
2025 (8142)
2024 (10119)
2023 (12002)
2022 (18220)
2021 (18998)
2020 (20041)
2019 (20142)
2018 (15193)
2017 (10084)
2016 (9920)
2015 (10969)
2014 (7886)
2013 (6836)
2012 (7604)
2011 (8132)
2010 (6982)
Location
Africa (237)
Alabama (19)
Alaska (4)
Arizona (90)
Arkansas (8)
Asia (10672)
Australia (1429)
California (2407)
Canada (1526)
China (195)
Colorado (202)
Connecticut (113)
Delaware (87)
Europe (28320)
Florida (428)
Georgia (102)
Hawaii (2)
Idaho (21)
Illinois (390)
India (29)
Indiana (142)
Iowa (5)
Japan (117)
Kansas (38)
Kentucky (24)
Louisiana (16)
Maine (28)
Maryland (497)
Massachusetts (1712)
Michigan (135)
Minnesota (165)
Mississippi (3)
Missouri (52)
Montana (10)
Nebraska (13)
Nevada (34)
New Hampshire (24)
New Jersey (835)
New Mexico (14)
New York (586)
North Carolina (605)
North Dakota (6)
Northern California (1074)
Ohio (146)
Oklahoma (13)
Oregon (9)
Pennsylvania (784)
Puerto Rico (11)
Rhode Island (20)
South America (396)
South Carolina (10)
Southern California (1007)
Tennessee (73)
Texas (490)
United States (10406)
Utah (68)
Vermont (1)
Virginia (60)
Washington D.C. (24)
Washington State (209)
West Virginia (4)
Wisconsin (54)
Wyoming (1)
223,480 Results for "hybrigenics services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Hybrigenics Re-brands to ‘ATON’ as Company Signals New Global Vision and Strategy to Advance Breakthrough Treatments
Hybrigenics, a leading French publicly listed bioscience firm, has today announced its re-brand to ‘ATON’ as it signifies the culmination of a transformative shift in its vision and strategy that began two years ago.
September 26, 2023
·
4 min read
Press Releases
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
February 2, 2026
·
2 min read
Press Releases
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Strategic Investments in the EU and US strengthen Vetter’s Global Footprint • Building permit application for German site submitted • Construction start is scheduled for the 2nd quarter 2026, with operational readiness in 2031 • Expansions in the US and Europe are included in a €1.5 billion investment plan
January 29, 2026
·
1 min read
Press Releases
Michigan Integrative Health Expands Stem Cell Therapy Services to Welcome Canadian Patients
February 4, 2026
·
2 min read
Press Releases
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
February 3, 2026
·
2 min read
Press Releases
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
January 14, 2026
·
8 min read
Press Releases
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
January 21, 2026
·
3 min read
Press Releases
Evestia Clinical Acquires ICRC-Weyer to Enhance Global Full-Service Clinical Research Capabilities
January 27, 2026
·
4 min read
Press Releases
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
December 16, 2025
·
16 min read
Press Releases
REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools
January 29, 2026
·
2 min read
1 of 22,348
Next
